The Food and Drug Administration Food Safety Modernization Act: Focus on Implementation Strategy for Prevention-Oriented Food Safety Standards; Public Meeting and Establishment of Docket, 15612-15614 [2015-06656]
Download as PDF
mstockstill on DSK4VPTVN1PROD with NOTICES
15612
Federal Register / Vol. 80, No. 56 / Tuesday, March 24, 2015 / Notices
Place: CDC, Building 19, Rooms
256/257, 1600 Clifton Road, NE.,
Atlanta, Georgia 30333.
Status: Open to the public, limited
only by the space available. The meeting
room accommodates approximately 50
people. The public is welcome to
participate during the public comment
period, which is tentatively scheduled
from 5:30 to 5:45 p.m. This meeting is
also available by teleconference, please
dial (866) 763–0273 and enter code
6158968.
Purpose: The Subcommittee will
provide advice to the CDC Director
through the ACD on strategic and other
health disparities and health equity
issues and provide guidance on
opportunities for CDC.
Matters To Be Discussed: The Health
Disparities Subcommittee members will
discuss health equity in injury
prevention, progress toward the ACD,
CDC-approved Health Disparities
Subcommittee recommendations, and
updates on selected priorities of the
Health Disparities Subcommittee.
The agenda is subject to change as
priorities dictate.
Web links:
Windows Media: https://
wm.onlinevideoservice.com/CDC1.
Flash: https://
www.onlinevideoservice.com/clients/
CDC/?mount=CDC3.
If you are unable to connect using the
link, copy and paste the link into your
web browser.
Number for Technical Support: 404–
639–3737.
Contact Person For More Information:
Leandris Liburd, Ph.D., M.P.H., M.A.,
Designated Federal Officer, Health
Disparities Subcommittee, Advisory
Committee to the Director, CDC, 1600
Clifton Road NE., M/S K–77, Atlanta,
Georgia 30333, Telephone 770–488–
8343, Email: LEL1@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention (CDC).
[FR Doc. 2015–06645 Filed 3–23–15; 8:45 am]
BILLING CODE 4163–18–P
VerDate Sep<11>2014
01:09 Mar 24, 2015
Jkt 235001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2015–N–0797]
The Food and Drug Administration
Food Safety Modernization Act: Focus
on Implementation Strategy for
Prevention-Oriented Food Safety
Standards; Public Meeting and
Establishment of Docket
AGENCY:
Food and Drug Administration,
HHS.
Notice of public meeting and
establishment of docket.
ACTION:
The Food and Drug
Administration (FDA or we) is
announcing the establishment of a
docket to obtain comments that will
inform our development of FDA Food
Safety Modernization Act (FSMA)
implementation work plans. FDA is also
announcing a public meeting entitled
‘‘FDA Food Safety Modernization Act:
Focus on Implementation Strategy for
Prevention-Oriented Food Safety
Standards.’’ At the public meeting, we
will share our current thinking on our
operational strategy for implementation
work plans. We will also provide
interested persons an opportunity to
provide input on this operational
strategy and the risk-based industry
oversight framework that is at the core
of FSMA.
DATES: See section III, ‘‘How to
Participate in the Public Meeting’’ in the
SUPPLEMENTARY INFORMATION section of
this document for dates and times of the
public meeting, closing dates for
advance registration, requesting special
accommodations due to disability, and
information on deadlines for submitting
either electronic or written comments to
FDA’s Division of Dockets Management.
ADDRESSES: See section III, ‘‘How to
Participate in the Public Meeting’’ in the
SUPPLEMENTARY INFORMATION section of
this document.
FOR FURTHER INFORMATION CONTACT: For
questions about registering for the
meeting or to register by phone:
Courtney Treece, Planning Professionals
Ltd., 1210 West McDermott Dr., suite
111, Allen, TX 75013, 704–258–4983,
FAX: 469–854–6992, email:
ctreece@planningprofessionals.com.
For general questions about the
meeting or for special accommodations
due to a disability: Juanita Yates, Center
for Food Safety and Applied Nutrition
(HFS–009), Food and Drug
Administration, 5100 Paint Branch
Pkwy., College Park, MD 20740, 240–
402–1731, email:
Juanita.yates@fda.hhs.gov.
SUMMARY:
PO 00000
Frm 00065
Fmt 4703
Sfmt 4703
SUPPLEMENTARY INFORMATION:
I. Background
The FDA Food Safety Modernization
Act (FSMA) (Pub. L. 111–353), signed
into law by President Obama on January
4, 2011, enables FDA to better protect
public health by helping to ensure the
safety and security of the food supply.
FSMA amends the Federal Food, Drug,
and Cosmetic Act to establish the
foundation of a modernized, preventionbased food safety system. Among other
things, FSMA requires FDA to issue
regulations regarding produce safety,
preventive controls for foods for
humans and animals, intentional
adulteration, the foreign supplier
verification program (FSVP), and the
FDA third-party accreditation program.
While FSMA reinforces industry’s
primary role and responsibility for food
safety, it also builds on and strengthens
FDA’s oversight role in establishing
food safety standards, fostering
compliance with those standards
through guidance and technical
assistance, and enforcing the standards
to protect public health when problems
occur. In fact, more so than ever before,
we are called upon by FSMA to play a
central leadership and operational role
in the future global food safety system.
Meeting this challenge—and
successfully implementing FSMA’s new
prevention-oriented, systems approach
to food safety—necessitates a new
strategy for how we perform our food
safety role and meet our new
responsibilities.
On May 2, 2014, we released our
‘‘Operational Strategy for Implementing
the FDA Food Safety Modernization Act
(FSMA),’’ available electronically at
https://www.fda.gov/Food/
GuidanceRegulation/FSMA/
ucm395105.htm, to guide the next phase
of FSMA implementation. The
operational strategy broadly outlines our
approach to food safety and the
operational strategy for our food safety
program and implementation of FSMA
after the rulemaking is complete. Within
the ‘‘Operational Strategy for
Implementing FSMA,’’ there is an
appendix that outlines guiding
principles for how the operational
strategy can be implemented with
respect to food and feed facilities,
produce safety standards, and import
oversight. The guiding principles
include the following: Expanding
inspection and surveillance;
administering new administrative
enforcement tools; developing guidance,
education, and technical assistance
tools; and building a preventionoriented import system.
E:\FR\FM\24MRN1.SGM
24MRN1
Federal Register / Vol. 80, No. 56 / Tuesday, March 24, 2015 / Notices
The public meeting is an opportunity
for interested persons to share views
concerning how FDA should address
the operational aspects of FSMA
implementation as suggested by the
guiding principles. However, the
guiding principles do not lay out an
exhaustive list of operational issues to
be considered. Therefore, interested
persons will have an opportunity at the
public meeting to share views and
suggest new ideas on a range of
operational issues that FDA might
consider in our FSMA implementation
approach. Furthermore, the public
meeting is an opportunity for FDA to
share our current thinking on our
implementation plans. We encourage
interested persons to provide feedback
on any ideas that we present at the
public meeting related to the
operational aspects of FSMA
implementation. We are also
establishing a docket to obtain
comments that will inform our
development of FSMA implementation
work plans. The agenda and other
documents will be accessible on our
FSMA Web site at https://www.fda.gov/
FSMA before the public meeting.
II. Purpose and Format of the Public
Meeting
FDA is holding this public meeting on
FSMA implementation to provide an
update on current planning efforts and
to receive input from the public to
inform the development of operational
work plans in the areas of produce
safety, preventive controls for foods for
humans and animals, measures to
address intentional adulteration, FSVP,
and the FDA third-party accreditation
program. Please note that input received
previously through our continued
engagement with interested parties as
part of the FSMA proposed rules’
rulemaking process will also be
considered in the development of
operational work plans. However, the
Agency will not accept any new
information or data submitted during
the public meeting or through the
docket to inform any rulemaking.
FDA will provide multiple
opportunities for individuals to actively
express their views. At the meeting,
following introductory presentations by
FDA, stakeholders will have an
opportunity to participate in their
choice of breakout sessions on the
topics discussed at the meeting and
engage in an open comment and
question and answer session. Interested
parties may also submit electronic or
written comments to the docket by May
26, 2015. Breakout sessions will cover
operational aspects of produce safety,
preventive controls for human and
animal food, intentional adulteration,
FSVP, and the FDA third-party
accreditation program, as well as
overarching topics. We invite the public
to provide information, share
experiences, and raise issues on topics
that will be addressed in the breakout
sessions including (but limited to):
increasing awareness/reaching the
regulated community, potential partners
on outreach and implementation, state
15613
of readiness, barriers to implementation,
training and education for industry and
regulators, guidance needs, promotion
of best practices, technical assistance,
data needs, inspection changes/
approaches, compliance and
enforcement issues, and long-term
implementation success.
There will be an opportunity for
stakeholders who are unable to
participate in person to join the meeting
via Web cast. (See section III of this
document for more information on the
Web cast option.)
III. How To Participate in the Public
Meeting
FDA is holding the public meeting on
April 23, 2015, from 8:30 a.m. to 5:30
p.m. and April 24, 2015, from 8:30 a.m.
to 12:30 p.m. Due to limited space and
time, we encourage all persons who
wish to attend the meeting to register in
advance. There is no fee to register for
the public meeting, and registration will
be on a first-come, first-served basis.
Onsite registration will be accepted, as
space permits, after all preregistered
attendees are seated. While there is not
a formal comment session planned for
the public meeting, it is anticipated that
stakeholders will have ample
opportunity to provide comments and
opinions during the public meeting
through their participation in breakout
sessions and in the dialogue and
question and answer session.
Table 1 of this document provides
information on participation in the
public meeting.
TABLE 1—INFORMATION ON PARTICIPATION IN THE MEETING AND ON SUBMITTING COMMENTS TO THE DOCKET
Dates
Attend public
meeting.
View Web cast ....
mstockstill on DSK4VPTVN1PROD with NOTICES
Preregister ...........
Request special
accommodations due to disability.
VerDate Sep<11>2014
Electronic addresses
Addresses
Other information
April 23, 2015,
from 8:30 a.m.
to 5:30 p.m.,
and April 24,
2015, from
8:30 a.m. to
12:30 p.m.
April 23, 2015,
from 8:30 a.m.
to 5:30 p.m.,
and April 24,
2015, from
8:30 a.m. to
12:30 p.m.
Register by April
16, 2015.
Please preregister at https://
www.fda.gov/Food/
NewsEventsWorkshopsMeetingsConferences/default.htm.
Washington Marriott at Metro
Center, 775 12th St. NW.,
Washington, DC 20005.
Registration check-in begins at 8
a.m.
Individuals who wish to participate by Web cast are asked to
preregister
at
https://
www.fda.gov/Food/
NewsEvents/.
WorkshopsMeetingsConferences/
default.htm.
Individuals who wish to participate in person are asked to
preregister
at
https://
www.fda.gov/Food/
NewsEvents/.
WorkshopsMeetingsConferences/
default.htm.
Juanita Yates, email: Juanita.yates@fda.hhs.gov.
......................................................
The Web cast will have closed
captioning.
We encourage the use of electronic registration, if possible.1.
There is no registration fee for
the public meeting.
Request by April
8, 2015.
01:09 Mar 24, 2015
Jkt 235001
PO 00000
Frm 00066
Fmt 4703
See FOR FURTHER INFORMATION CONTACT.
Sfmt 4703
E:\FR\FM\24MRN1.SGM
24MRN1
15614
Federal Register / Vol. 80, No. 56 / Tuesday, March 24, 2015 / Notices
TABLE 1—INFORMATION ON PARTICIPATION IN THE MEETING AND ON SUBMITTING COMMENTS TO THE DOCKET—
Continued
Dates
Submit electronic
or written comments.
Electronic addresses
Addresses
Other information
Submit comments by May
26, 2015.
Federal eRulemaking Portal:
https://www.regulations.gov. Follow the instructions for submitting comments.
Mail/Hand delivery/Courier (for
paper submissions): Division of
Dockets Management (HFA–
305), Food and Drug Administration, 5630 Fishers Lane, rm.
1061, Rockville, MD 20852.
Identify your comments with the
docket number listed in brackets in the heading of this document. We encourage you to
submit electronic comments by
using the Federal eRulemaking
Portal.
1 You may also register via email, mail, or fax. Please include your name, title, firm name, address, and phone and fax numbers in your registration information and send to: Courtney Treece, Planning Professionals Ltd., 1210 West McDermott Dr., suite 111, Allen, TX 75013, 704–
258–4983, FAX: 469–854–6992, email: ctreece@planningprofessionals.com.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Regardless of attendance at the public
meeting, interested persons may submit
to FDA’s Division of Dockets
Management (see Addresses in table 1 of
this document) either electronic or
written comments on FSMA
implementation issues. You only need
to send one set of comments. Identify
the comments with the docket number
listed in brackets in the heading of this
document. However, we will not use
any information or data submitted
during the public meeting or through
the docket to inform any FSMA
rulemakings where the comment
periods have closed.
With respect to transcripts, please be
advised that as soon as a transcript is
available it will be accessible at https://
www.regulations.gov and at FDA’s
FSMA Web site at https://www.fda.gov/
FSMA. You may also view the transcript
at the Division of Dockets Management
(HFA–305), Food and Drug
Administration, 5630 Fishers Lane, rm.
1061, Rockville, MD 20852. A transcript
will also be available in either hardcopy
or on CD–ROM, after submission of a
Freedom of Information request. Send
written requests to the Division of
Freedom of Information (ELEM–1029),
12420 Parklawn Dr., Element Bldg.,
Rockville, MD 20857.
Additionally, we will be video
recording the public meeting. Once the
recorded video is available, it will be
accessible at FDA’s FSMA Web site at
https://www.fda.gov/FSMA.
mstockstill on DSK4VPTVN1PROD with NOTICES
IV. Comments, Transcripts, and
Recorded Video
Centers for Disease Control and
Prevention
Agency for Toxic Substances and
Disease Registry
Interagency Committee on Smoking
and Health: Notice of Charter Renewal
This gives notice under the Federal
Advisory Committee Act (Pub. L. 92–
463) of October 6, 1972, that the
Interagency Committee on Smoking and
Health, Department of Health and
Human Services, has been renewed for
a 2-year period through March 20, 2017.
For information, contact Simon
McNabb, Designated Federal Officer,
Interagency Committee on Smoking and
Health, Centers for Disease Control and
Prevention, Department of Health and
Human Services, Patriot’s Plaza, 395 E
Street SW., M/S P06, Washington, DC
20201, telephone 202/245–0550 or fax
202/245–0599, Email: BOL1@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2015–06649 Filed 3–23–15; 8:45 am]
BILLING CODE 4163–18–P
Dated: March 18, 2015.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2015–06656 Filed 3–23–15; 8:45 am]
BILLING CODE 4164–01–P
VerDate Sep<11>2014
01:09 Mar 24, 2015
Jkt 235001
PO 00000
Frm 00067
Fmt 4703
Sfmt 4703
[60Day–15–15TG; Docket No. CDC–2015–
0009]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Agency for Toxic Substances
and Disease Registry (ATSDR), Centers
for Disease Control and Prevention
(CDC).
ACTION: Notice with comment period.
AGENCY:
The Agency for Toxic
Substances and Disease Registry
(ATSDR), as part of its continuing
efforts to reduce public burden and
maximize the utility of government
information, invites the general public
and other Federal agencies to take this
opportunity to comment on proposed
and/or continuing information
collections, as required by the
Paperwork Reduction Act of 1995. This
notice invites comment on Promotion of
the National Amyotrophic Lateral
Sclerosis (ALS) Registry to Non-referral
Centers.
DATES: Written comments must be
received on or before May 26, 2015.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2015–
0009 by any of the following methods:
• Federal eRulemaking Portal:
Regulation.gov. Follow the instructions
for submitting comments.
• Mail: Leroy A. Richardson,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE., MS–
D74, Atlanta, Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. All relevant comments
received will be posted without change
to Regulations.gov, including any
personal information provided. For
access to the docket to read background
SUMMARY:
E:\FR\FM\24MRN1.SGM
24MRN1
Agencies
[Federal Register Volume 80, Number 56 (Tuesday, March 24, 2015)]
[Notices]
[Pages 15612-15614]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-06656]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2015-N-0797]
The Food and Drug Administration Food Safety Modernization Act:
Focus on Implementation Strategy for Prevention-Oriented Food Safety
Standards; Public Meeting and Establishment of Docket
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice of public meeting and establishment of docket.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA or we) is announcing the
establishment of a docket to obtain comments that will inform our
development of FDA Food Safety Modernization Act (FSMA) implementation
work plans. FDA is also announcing a public meeting entitled ``FDA Food
Safety Modernization Act: Focus on Implementation Strategy for
Prevention-Oriented Food Safety Standards.'' At the public meeting, we
will share our current thinking on our operational strategy for
implementation work plans. We will also provide interested persons an
opportunity to provide input on this operational strategy and the risk-
based industry oversight framework that is at the core of FSMA.
DATES: See section III, ``How to Participate in the Public Meeting'' in
the SUPPLEMENTARY INFORMATION section of this document for dates and
times of the public meeting, closing dates for advance registration,
requesting special accommodations due to disability, and information on
deadlines for submitting either electronic or written comments to FDA's
Division of Dockets Management.
ADDRESSES: See section III, ``How to Participate in the Public
Meeting'' in the SUPPLEMENTARY INFORMATION section of this document.
FOR FURTHER INFORMATION CONTACT: For questions about registering for
the meeting or to register by phone: Courtney Treece, Planning
Professionals Ltd., 1210 West McDermott Dr., suite 111, Allen, TX
75013, 704-258-4983, FAX: 469-854-6992, email:
ctreece@planningprofessionals.com.
For general questions about the meeting or for special
accommodations due to a disability: Juanita Yates, Center for Food
Safety and Applied Nutrition (HFS-009), Food and Drug Administration,
5100 Paint Branch Pkwy., College Park, MD 20740, 240-402-1731, email:
Juanita.yates@fda.hhs.gov.
SUPPLEMENTARY INFORMATION:
I. Background
The FDA Food Safety Modernization Act (FSMA) (Pub. L. 111-353),
signed into law by President Obama on January 4, 2011, enables FDA to
better protect public health by helping to ensure the safety and
security of the food supply. FSMA amends the Federal Food, Drug, and
Cosmetic Act to establish the foundation of a modernized, prevention-
based food safety system. Among other things, FSMA requires FDA to
issue regulations regarding produce safety, preventive controls for
foods for humans and animals, intentional adulteration, the foreign
supplier verification program (FSVP), and the FDA third-party
accreditation program.
While FSMA reinforces industry's primary role and responsibility
for food safety, it also builds on and strengthens FDA's oversight role
in establishing food safety standards, fostering compliance with those
standards through guidance and technical assistance, and enforcing the
standards to protect public health when problems occur. In fact, more
so than ever before, we are called upon by FSMA to play a central
leadership and operational role in the future global food safety
system. Meeting this challenge--and successfully implementing FSMA's
new prevention-oriented, systems approach to food safety--necessitates
a new strategy for how we perform our food safety role and meet our new
responsibilities.
On May 2, 2014, we released our ``Operational Strategy for
Implementing the FDA Food Safety Modernization Act (FSMA),'' available
electronically at https://www.fda.gov/Food/GuidanceRegulation/FSMA/ucm395105.htm, to guide the next phase of FSMA implementation. The
operational strategy broadly outlines our approach to food safety and
the operational strategy for our food safety program and implementation
of FSMA after the rulemaking is complete. Within the ``Operational
Strategy for Implementing FSMA,'' there is an appendix that outlines
guiding principles for how the operational strategy can be implemented
with respect to food and feed facilities, produce safety standards, and
import oversight. The guiding principles include the following:
Expanding inspection and surveillance; administering new administrative
enforcement tools; developing guidance, education, and technical
assistance tools; and building a prevention-oriented import system.
[[Page 15613]]
The public meeting is an opportunity for interested persons to
share views concerning how FDA should address the operational aspects
of FSMA implementation as suggested by the guiding principles. However,
the guiding principles do not lay out an exhaustive list of operational
issues to be considered. Therefore, interested persons will have an
opportunity at the public meeting to share views and suggest new ideas
on a range of operational issues that FDA might consider in our FSMA
implementation approach. Furthermore, the public meeting is an
opportunity for FDA to share our current thinking on our implementation
plans. We encourage interested persons to provide feedback on any ideas
that we present at the public meeting related to the operational
aspects of FSMA implementation. We are also establishing a docket to
obtain comments that will inform our development of FSMA implementation
work plans. The agenda and other documents will be accessible on our
FSMA Web site at https://www.fda.gov/FSMA before the public meeting.
II. Purpose and Format of the Public Meeting
FDA is holding this public meeting on FSMA implementation to
provide an update on current planning efforts and to receive input from
the public to inform the development of operational work plans in the
areas of produce safety, preventive controls for foods for humans and
animals, measures to address intentional adulteration, FSVP, and the
FDA third-party accreditation program. Please note that input received
previously through our continued engagement with interested parties as
part of the FSMA proposed rules' rulemaking process will also be
considered in the development of operational work plans. However, the
Agency will not accept any new information or data submitted during the
public meeting or through the docket to inform any rulemaking.
FDA will provide multiple opportunities for individuals to actively
express their views. At the meeting, following introductory
presentations by FDA, stakeholders will have an opportunity to
participate in their choice of breakout sessions on the topics
discussed at the meeting and engage in an open comment and question and
answer session. Interested parties may also submit electronic or
written comments to the docket by May 26, 2015. Breakout sessions will
cover operational aspects of produce safety, preventive controls for
human and animal food, intentional adulteration, FSVP, and the FDA
third-party accreditation program, as well as overarching topics. We
invite the public to provide information, share experiences, and raise
issues on topics that will be addressed in the breakout sessions
including (but limited to): increasing awareness/reaching the regulated
community, potential partners on outreach and implementation, state of
readiness, barriers to implementation, training and education for
industry and regulators, guidance needs, promotion of best practices,
technical assistance, data needs, inspection changes/approaches,
compliance and enforcement issues, and long-term implementation
success.
There will be an opportunity for stakeholders who are unable to
participate in person to join the meeting via Web cast. (See section
III of this document for more information on the Web cast option.)
III. How To Participate in the Public Meeting
FDA is holding the public meeting on April 23, 2015, from 8:30 a.m.
to 5:30 p.m. and April 24, 2015, from 8:30 a.m. to 12:30 p.m. Due to
limited space and time, we encourage all persons who wish to attend the
meeting to register in advance. There is no fee to register for the
public meeting, and registration will be on a first-come, first-served
basis. Onsite registration will be accepted, as space permits, after
all preregistered attendees are seated. While there is not a formal
comment session planned for the public meeting, it is anticipated that
stakeholders will have ample opportunity to provide comments and
opinions during the public meeting through their participation in
breakout sessions and in the dialogue and question and answer session.
Table 1 of this document provides information on participation in
the public meeting.
Table 1--Information on Participation in the Meeting and on Submitting Comments to the Docket
----------------------------------------------------------------------------------------------------------------
Dates Electronic addresses Addresses Other information
----------------------------------------------------------------------------------------------------------------
Attend public meeting........ April 23, 2015, Please preregister Washington Marriott Registration check-
from 8:30 a.m. at https:// at Metro Center, in begins at 8 a.m.
to 5:30 p.m., www.fda.gov/Food/ 775 12th St. NW.,
and April 24, NewsEventsWorkshops Washington, DC
2015, from MeetingsConferences/ 20005.
8:30 a.m. to default.htm.
12:30 p.m.
View Web cast................ April 23, 2015, Individuals who wish .................... The Web cast will
from 8:30 a.m. to participate by have closed
to 5:30 p.m., Web cast are asked captioning.
and April 24, to preregister at
2015, from https://www.fda.gov/
8:30 a.m. to Food/NewsEvents/.
12:30 p.m. WorkshopsMeetingsCon
ferences/
default.htm.
Preregister.................. Register by Individuals who wish We encourage the use There is no
April 16, 2015. to participate in of electronic registration fee
person are asked to registration, if for the public
preregister at possible.\1\. meeting.
https://www.fda.gov/Food/NewsEvents/ Food/NewsEvents/.
WorkshopsMeetingsCon
ferences/
default.htm.
Request special Request by Juanita Yates, See FOR FURTHER ....................
accommodations due to April 8, 2015. email: INFORMATION CONTACT.
disability. Juanita.yates@fda.hhs.gov.
[[Page 15614]]
Submit electronic or written Submit comments Federal eRulemaking Mail/Hand delivery/ Identify your
comments. by May 26, Portal: https:// Courier (for paper comments with the
2015. www.regulations.gov submissions): docket number
. Follow the Division of Dockets listed in brackets
instructions for Management (HFA- in the heading of
submitting comments. 305), Food and Drug this document. We
Administration, encourage you to
5630 Fishers Lane, submit electronic
rm. 1061, comments by using
Rockville, MD 20852. the Federal
eRulemaking Portal.
----------------------------------------------------------------------------------------------------------------
\1\ You may also register via email, mail, or fax. Please include your name, title, firm name, address, and
phone and fax numbers in your registration information and send to: Courtney Treece, Planning Professionals
Ltd., 1210 West McDermott Dr., suite 111, Allen, TX 75013, 704-258-4983, FAX: 469-854-6992, email:
ctreece@planningprofessionals.com.
IV. Comments, Transcripts, and Recorded Video
Regardless of attendance at the public meeting, interested persons
may submit to FDA's Division of Dockets Management (see Addresses in
table 1 of this document) either electronic or written comments on FSMA
implementation issues. You only need to send one set of comments.
Identify the comments with the docket number listed in brackets in the
heading of this document. However, we will not use any information or
data submitted during the public meeting or through the docket to
inform any FSMA rulemakings where the comment periods have closed.
With respect to transcripts, please be advised that as soon as a
transcript is available it will be accessible at https://www.regulations.gov and at FDA's FSMA Web site at https://www.fda.gov/FSMA. You may also view the transcript at the Division of Dockets
Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane,
rm. 1061, Rockville, MD 20852. A transcript will also be available in
either hardcopy or on CD-ROM, after submission of a Freedom of
Information request. Send written requests to the Division of Freedom
of Information (ELEM-1029), 12420 Parklawn Dr., Element Bldg.,
Rockville, MD 20857.
Additionally, we will be video recording the public meeting. Once
the recorded video is available, it will be accessible at FDA's FSMA
Web site at https://www.fda.gov/FSMA.
Dated: March 18, 2015.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2015-06656 Filed 3-23-15; 8:45 am]
BILLING CODE 4164-01-P